Exelixis Inc. kicked off the trading day on 10/10/19 with a price increase of 1.57%, equivalent to $0.26 relative change for the day. Taking a more long-term approach, EXEL had a 52-week range of $13.42 to $25.31. At the time of this article’s publishing, this stock is trading at $16.53 after starting the trading session at $16.27. At the time of writing, this stock’s 50-day Moving Average stands at $19.33, while the 200-day Moving Average of this stock is currently $21.10.
Currently, this company’s share volume is sitting at $2488803, but has maintained average daily volume of $2.57M. This stock has generated an average Year to Date volume of $3.11 million, alongside an average 20-day volume of $2.54 million. This publicly-traded company’s shares outstanding now amounts to $318.91 million, simultaneously with a float of $292.81 million. The organization now has a market capitalization sitting at $5.27 billion.
Exelixis Inc.(EXEL) Ownership Data
Now let’s turn our focus to how large-scale investors are behaving with this stock. Exelixis Inc.’s current insider ownership accounts for 1.30%, in contrast to 80.10% institutional ownership. According to the most recent latest insider trade that took place on Oct 02 this organization’s President and CEO exercised an option 35,409 at the rate of 7.18, making the entire transaction hit 254,237 in total value, affecting insider ownership by 231,513. Preceding that transaction, on Oct 02 Company’s President and CEO sold 26,364 at a price of 17.66, making the whole transaction’s value amount to 465,588. This particular insider is now the holder of 205,149 in total.
If we take a glance at the Ownership summary of Exelixis Inc.’s stock, Institutional holders make up 80.10% of its total stock ownership. All together, they are the legal holders of 318.91M shares. If we focus on the top 3 stockholders for this publicly-traded organization, BlackRock Fund Advisors owns 28,472,264 shares, with The Vanguard Group, Inc. in 2nd place owning 27,593,434 shares and Fidelity Management & Research Co. in third place with total ownership of 16,323,220 shares.
Exelixis Inc. (EXEL) Earnings and Revenue Data
In the latest quarterly report that this company released, which was put into the public domain on 6/29/2019, the organization reported $0.25 earnings per share (EPS) for the three-month period, surpassing the consensus estimate (set at $0.23) by $0.02.
This company achieved a net margin of 70.52 while generating a return on equity of 54.81. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.22 per share during the current fiscal year.
Exelixis Inc.’s EPS increase for this current 12-month fiscal period is 346.30%, and is forecasted to reach 1.14 in the upcoming year. Looking at the long run, market analysts have predicted that Company’s EPS will increase by 46.00% through the next 5 years, which can be compared against the 29.60% growth it accomplished over the previous five years trading on the market.
Additional Trading Performance Indicators
Now turning our attention to the current performance indicators for Exelixis Inc., this organization’s Quick Ratio in the last reported quarter now stands at 8.50. The company has managed to achieve an average true range (ATR) of 0.65. Alongside those, its PE Ratio stands at $8.05, and its Beta score is 1.78.
Another valuable indicator worth considering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 5.79 for this organization. Similarly, its price to free cash flow for trailing twelve months is now 9.75. Plus, this company’s price to book ratio for the last three-month fiscal period reported is 3.35, whereas its price to cash per share for the last quarter landed at 2.58.
In the same vein, EXEL’s Diluted EPS (Earnings per Share) trailing twelve months was posted at 2.05, a figure that is expected to reach 0.19 in the next reported quarter, and analysts expect it will be 1.14 at the market close of one year from today’s date.